Medytox Solutions, Inc. 4
4 · Medytox Solutions, Inc. · Filed Nov 20, 2015
Insider Transaction Report
Form 4
Frank Benjamin
Director
Transactions
- Disposition to Issuer
Options to Purchase Common Stock
2015-11-02+50,000→ 0 totalExercise: $5.00From: 2014-04-19Exp: 2017-04-19→ Common Stock (50,000 underlying) - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02+100,000→ 0 totalExercise: $2.50From: 2013-04-19Exp: 2017-04-19→ Common Stock (100,000 underlying) - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02+50,000→ 0 totalExercise: $2.50From: 2014-04-19Exp: 2017-04-19→ Common Stock (50,000 underlying) - Disposition to Issuer
Options to Purchase Common Stock
2015-11-02+100,000→ 0 totalExercise: $5.00From: 2013-04-19Exp: 2017-04-19→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Cancelled pursuant to merger agreement and related transactions among Medytox Solutions, Inc. ("Medytox"), CollabRx Merger Sub, Inc. ("Merger Sub") and Rennova Health, Inc. ("Rennova") (f/k/a/ CollabRx, Inc.).
- [F2]Disposed of pursuant to merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 40,963 shares of Rennova common stock at an exercise price of $6.11 per share.
- [F3]Disposed of pursuant to merger agreement among Medytox, Merger Sub and Rennova. The options were assumed by Rennova in the merger and replaced with options to purchase 20,481 shares of Rennova common stock at an exercise price of $6.11 per share.